Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549211 · ClinicalTrials.gov registry record · Phase 1
A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00549211 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 42 participants.
The verdict
NCT00549211, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
A study conducted on healthy volunteers to determine the safety, tolerability and affect on the human body by experimental drug GSK557296.
Interventions
- DRUG GSK557296
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2007-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00549211
The ClinicalTrials.gov registry entry for NCT00549211 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK557296 is the first listed.
NCT00549211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00549211 about?
NCT00549211 is a clinical study titled "A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.". A study conducted on healthy volunteers to determine the safety, tolerability and affect on the human body by experimental drug GSK557296.
What is the current status of trial NCT00549211?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2007-10.
What interventions are being tested in trial NCT00549211?
The interventions under investigation include: GSK557296 (DRUG).
Who is sponsoring clinical trial NCT00549211?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.